InvestorsHub Logo

georgejjl

03/21/19 3:14 PM

#186165 RE: Gator328 #186163

BIIB has 4 times the number of shares as AVXL so multiply BIIB share price by 4 and AVXL would still be undervalued if Anavex 2-73 becomes the standard of care for Alzheimer's disease, and Parkinson's, etc.

Good luck and GOD bless,

jimmy667

03/21/19 3:24 PM

#186169 RE: Gator328 #186163

Ok Gator explain the disparity in the Market Caps of Anavex and AXON during most of its time in "the Limelight" 1.5 Bill or equal to $38 per share for Anavex. Or to legit pre approval no revenue company SAGE in the 7 bill range with no approved drugs and zero revenue targeting depression.
Oh and way was AXON on Wall Street radar even making Oppenhiemers Conviction Buy list?
Anyone that listens to Wall Street is buying their trash at an inflated price.
But you always seem to have the answers so I am all ears my friend who always wants to buy Anavex but much lower.

cninc

03/21/19 4:16 PM

#186185 RE: Gator328 #186163

Goldman put a value on BIIB Az drug @ 12 bill